Cannabis Science Inc (CBIS) 0.0157 $CBIS
CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW!
Marketwire Canada - Thu Jun 02, 10:01AM CDT
NEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based in Germany, released the newest innovative product line: Canna POW! The first worldwide, premium quality, water soluble Cannabis Instant Beverage: Canna POW! Is starting distribution June 1, 2016, in Europe and Internationally.
CBIS African Delegation Arrives in Johannesburg, South Africa After Successful Cape Town Meetings With South African Parliament Members, University Cannabis Research Specialists, and Tour of NIH Equivalent, South African Medical Research Council (MRC)
Marketwired - Wed May 25, 8:44AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 25, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines -- The CBIS delegation led by Mr. Raymond C. Dabney has arrived in Johannesburg, South Africa after a series of successful meetings and in-depth discussions in Cape Town, South Africa with South African Parliament members, key University cannabis research specialists, private industry front-runners, topped off with a tour and meetings with key executives at the South African Medical Research Council (MRC) which is the NIH equivalent research organization in South Africa.
Cannabis Science Delegation Arrives in South Africa to Launch a Historic Africa Healthcare Initiative Led by President & CEO, Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Mon May 23, 7:31AM CDT
CAPE TOWN, SOUTH AFRICA--(Marketwired - May 23, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces arrival of a Cannabis Science delegation beginning in Cape Town, South Africa to launch a historic Africa Healthcare initiative led by President & CEO, Co-Founder Raymond C. Dabney.
CBIS Gets Set to Break Ground on Its 360,000 sq. ft. Ft. McDermitt Drug Development Project; Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands Tours Property With Investors/Licensees With 1 Million sq. ft. of Cultivation Licenses
Marketwired - Mon May 09, 7:51AM CDT
Ft. McDermitt Allotment Allottees Lands, Which Is on the Ft. McDermitt Tribal Reservation, the Project Will Benefit Both Ft. McDermitt Tribe Members and Allotment Allottees
Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
Marketwire Canada - Fri May 06, 8:30AM CDT
LOS ANGELES, CA--(Marketwired - May 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
Marketwire Canada - Wed May 04, 9:22AM CDT
COLORADO SPRINGS, CO--(Marketwired - May 4, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
Marketwired - Tue May 03, 10:22AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, is currently processing more than 3,000 shareholder requests for their "loyalty gift" from CEO Raymond C. Dabney. This is a remarkable number to say the least, as the company draws near the release of the schematics for its 360,000 sq. ft., Nevada drug development complex later this week.
CrowdGather (CRWG) Parlays Social Casino Business to Bet on Digital Cannabis
ACCESSWIRE - Wed Apr 27, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 27, 2016 / The cannabis industry could reach $35 billion by 2020, according to GreenWave Advisors, driven by legalization in a growing number of states. Within this so-called green rush, investors have a number of different investment opportunities. Cannabis Science Inc. (OTC: CBIS) provides investors with exposure to the research side of the business, while American Cannabis Company (OTC: AMMJ) is focused on consulting services.
Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products
PR Newswire - Wed Apr 20, 7:30AM CDT
Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with current operations and developments of importance in the markets today are New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Cara Therapeutics (NASDAQ: CARA), Terra Tech Corp. (OTC: TRTC) and Cannabis Sativa Inc. (OTCBB: CBDS).
CARA: 6.25 (-0.20), GWPH: 92.09 (-1.32)
Cannabis Science Congratulates and Welcomes the State of Pennsylvania as the 24th State to Legalize Medical Cannabis
Marketwired - Mon Apr 18, 8:24AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to extend its congratulations to the State of Pennsylvania as the 24th state to legalize cannabis for medical purposes.
Cannabis Science CEO Pleasantly Surprised That Over 1,000 Investors in the First 48 Hours Have Registered Successfully for the Gift Shares; Nevada Property Forges Forward With Updated Renderings and Land Parcel Schematics
Marketwired - Thu Apr 14, 9:53AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is very pleased to report CEO Raymond C. Dabney has received an overwhelmingly successful response with over 1,000 shareholders in less than 48 hours successfully registering for the personal stock gift.
Cannabis Science Is Very Excited as the DEA Considers to Reschedule Marijuana/Cannabis With a Landmark Decision as Early as Mid-Year, 2016
Marketwired - Wed Apr 06, 8:03AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today acknowledges and is very excited about the Landmark move with the Drug Enforcement Agency's (DEA) decision to review marijuana's federal drug classification as early as mid-2016. Rescheduling marijuana would ease restrictions on research across the country, while at the same time reducing penalties for marijuana offenses. Increased research capabilities could spur innovation and growth in the cannabis industry.
The Cannabis Science 360,000 Sq. Ft., Drug Development Compound Educational, Medical Facilities, and Laboratory in Nevada Presents a Fully Licensed Opportunity for Additional 900,000 Sq. Ft., for Investment Tender to the Qualified Public
Marketwired - Mon Apr 04, 8:38AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they have taken another step to improve the company's bottom line for United States cannabinoid pharmaceutical drug development programs. The Company also announced its new toll-free number 1-888-263-0832, as the President phone line has been inundated with cheer over the gifted share program. Please call the new number to ensure your information is documented. Once the Company website has been updated, a news release will point everyone in the right directions.
Cannabis Science CEO Excited as Record Date for Gifted Shares Approaches Tomorrow, Thursday, March 31st, 2016, and the New 360,000 Sq. Ft., Nevada Facility Moves to Design Phase
Marketwired - Wed Mar 30, 8:02AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, has announced that the Cannabis Science CEO is excited as record date for gifted shares approaches fast, tomorrow, Thursday, March 31st, 2016, and the new 360,000 sq. ft. facility in Nevada moves into design phase.
The Last Time This Company Made A FDA Submission It Ran 2,100%-- Here's Why You Should Be Looking At It Right Now
ACCESSWIRE - Wed Mar 30, 6:00AM CDT
WINDSOR, ON / ACCESSWIRE / March 30, 2016 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to highlight that the maximum gains are made by investors who seek out promising pharma companies before their filing of FDA approval.
AGEN: 4.38 (-0.12), ARGS: 6.21 (+0.02)
CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW!
Marketwire Canada - Thu Jun 02, 10:01AM CDT
NEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based in Germany, released the newest innovative product line: Canna POW! The first worldwide, premium quality, water soluble Cannabis Instant Beverage: Canna POW! Is starting distribution June 1, 2016, in Europe and Internationally.
CBIS African Delegation Arrives in Johannesburg, South Africa After Successful Cape Town Meetings With South African Parliament Members, University Cannabis Research Specialists, and Tour of NIH Equivalent, South African Medical Research Council (MRC)
Marketwired - Wed May 25, 8:44AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 25, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines -- The CBIS delegation led by Mr. Raymond C. Dabney has arrived in Johannesburg, South Africa after a series of successful meetings and in-depth discussions in Cape Town, South Africa with South African Parliament members, key University cannabis research specialists, private industry front-runners, topped off with a tour and meetings with key executives at the South African Medical Research Council (MRC) which is the NIH equivalent research organization in South Africa.
Cannabis Science Delegation Arrives in South Africa to Launch a Historic Africa Healthcare Initiative Led by President & CEO, Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Mon May 23, 7:31AM CDT
CAPE TOWN, SOUTH AFRICA--(Marketwired - May 23, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces arrival of a Cannabis Science delegation beginning in Cape Town, South Africa to launch a historic Africa Healthcare initiative led by President & CEO, Co-Founder Raymond C. Dabney.
CBIS Gets Set to Break Ground on Its 360,000 sq. ft. Ft. McDermitt Drug Development Project; Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands Tours Property With Investors/Licensees With 1 Million sq. ft. of Cultivation Licenses
Marketwired - Mon May 09, 7:51AM CDT
Ft. McDermitt Allotment Allottees Lands, Which Is on the Ft. McDermitt Tribal Reservation, the Project Will Benefit Both Ft. McDermitt Tribe Members and Allotment Allottees
Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
Marketwire Canada - Fri May 06, 8:30AM CDT
LOS ANGELES, CA--(Marketwired - May 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
Marketwire Canada - Wed May 04, 9:22AM CDT
COLORADO SPRINGS, CO--(Marketwired - May 4, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
Marketwired - Tue May 03, 10:22AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, is currently processing more than 3,000 shareholder requests for their "loyalty gift" from CEO Raymond C. Dabney. This is a remarkable number to say the least, as the company draws near the release of the schematics for its 360,000 sq. ft., Nevada drug development complex later this week.
CrowdGather (CRWG) Parlays Social Casino Business to Bet on Digital Cannabis
ACCESSWIRE - Wed Apr 27, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 27, 2016 / The cannabis industry could reach $35 billion by 2020, according to GreenWave Advisors, driven by legalization in a growing number of states. Within this so-called green rush, investors have a number of different investment opportunities. Cannabis Science Inc. (OTC: CBIS) provides investors with exposure to the research side of the business, while American Cannabis Company (OTC: AMMJ) is focused on consulting services.
Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products
PR Newswire - Wed Apr 20, 7:30AM CDT
Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with current operations and developments of importance in the markets today are New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Cara Therapeutics (NASDAQ: CARA), Terra Tech Corp. (OTC: TRTC) and Cannabis Sativa Inc. (OTCBB: CBDS).
CARA: 6.25 (-0.20), GWPH: 92.09 (-1.32)
Cannabis Science Congratulates and Welcomes the State of Pennsylvania as the 24th State to Legalize Medical Cannabis
Marketwired - Mon Apr 18, 8:24AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to extend its congratulations to the State of Pennsylvania as the 24th state to legalize cannabis for medical purposes.
Cannabis Science CEO Pleasantly Surprised That Over 1,000 Investors in the First 48 Hours Have Registered Successfully for the Gift Shares; Nevada Property Forges Forward With Updated Renderings and Land Parcel Schematics
Marketwired - Thu Apr 14, 9:53AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is very pleased to report CEO Raymond C. Dabney has received an overwhelmingly successful response with over 1,000 shareholders in less than 48 hours successfully registering for the personal stock gift.
Cannabis Science Is Very Excited as the DEA Considers to Reschedule Marijuana/Cannabis With a Landmark Decision as Early as Mid-Year, 2016
Marketwired - Wed Apr 06, 8:03AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today acknowledges and is very excited about the Landmark move with the Drug Enforcement Agency's (DEA) decision to review marijuana's federal drug classification as early as mid-2016. Rescheduling marijuana would ease restrictions on research across the country, while at the same time reducing penalties for marijuana offenses. Increased research capabilities could spur innovation and growth in the cannabis industry.
The Cannabis Science 360,000 Sq. Ft., Drug Development Compound Educational, Medical Facilities, and Laboratory in Nevada Presents a Fully Licensed Opportunity for Additional 900,000 Sq. Ft., for Investment Tender to the Qualified Public
Marketwired - Mon Apr 04, 8:38AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they have taken another step to improve the company's bottom line for United States cannabinoid pharmaceutical drug development programs. The Company also announced its new toll-free number 1-888-263-0832, as the President phone line has been inundated with cheer over the gifted share program. Please call the new number to ensure your information is documented. Once the Company website has been updated, a news release will point everyone in the right directions.
Cannabis Science CEO Excited as Record Date for Gifted Shares Approaches Tomorrow, Thursday, March 31st, 2016, and the New 360,000 Sq. Ft., Nevada Facility Moves to Design Phase
Marketwired - Wed Mar 30, 8:02AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, has announced that the Cannabis Science CEO is excited as record date for gifted shares approaches fast, tomorrow, Thursday, March 31st, 2016, and the new 360,000 sq. ft. facility in Nevada moves into design phase.
The Last Time This Company Made A FDA Submission It Ran 2,100%-- Here's Why You Should Be Looking At It Right Now
ACCESSWIRE - Wed Mar 30, 6:00AM CDT
WINDSOR, ON / ACCESSWIRE / March 30, 2016 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to highlight that the maximum gains are made by investors who seek out promising pharma companies before their filing of FDA approval. AGEN: 4.38 (-0.12), ARGS: 6.21 (+0.02)
